Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **follicle anagen phase** is not a molecule, receptor, or druggable biological target, but rather refers to the active growth phase of the hair follicle cycle. In this phase, the hair follicle is highly proliferative, rapidly producing new cells that become the hair shaft and internal root sheath[1][2][3][5][6]. The anagen phase can last from 2 to 7 years on the scalp, determines the length of hair, and is regulated by hormonal and molecular signals such as epidermal growth factors and the activity of follicular stem cells. Most scalp hair follicles are typically in the anagen phase at any given time. This is a physiological process rather than a single molecular entity, and thus it is not a therapeutic target like an enzyme or receptor. The terms "follicle anagen phase," "anagen phase," and "hair anagen phase" are commonly used interchangeably in scientific literature to describe the same stage of the hair cycle[1][2][6]. **Note:** There is a fundamental error: “Follicle anagen phase” describes a physiological state of the hair follicle, not a molecular target, receptor, or protein. It does not have a canonical abbreviation, is not a drug target, and has no associated drugs, mechanisms, or biomarkers. If you are seeking a molecular or pharmacological target related to hair growth regulation, you might search for factors such as the **androgen receptor**, **fibroblast growth factor receptors (FGFRs)**, or **epidermal growth factor receptor (EGFR)**, all of which influence hair follicle cycling, but “follicle anagen phase” itself is not the canonical name of a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Follicle anagen phase.